Annual FCF
-$16.88 M
+$2.02 M+10.67%
December 31, 2024
Summary
- As of March 6, 2025, NVNO annual free cash flow is -$16.88 million, with the most recent change of +$2.02 million (+10.67%) on December 31, 2024.
- During the last 3 years, NVNO annual FCF has fallen by -$4.66 million (-38.14%).
- NVNO annual FCF is now -734.53% below its all-time high of -$2.02 million, reached on December 31, 2015.
Performance
NVNO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.11 M
-$824.00 K-19.23%
December 31, 2024
Summary
- As of March 6, 2025, NVNO quarterly free cash flow is -$5.11 million, with the most recent change of -$824.00 thousand (-19.23%) on December 31, 2024.
- Over the past year, NVNO quarterly FCF has dropped by -$824.00 thousand (-19.23%).
- NVNO quarterly FCF is now -738.09% below its all-time high of -$609.60 thousand, reached on March 31, 2017.
Performance
NVNO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$16.88 M
-$132.00 K-0.79%
December 31, 2024
Summary
- As of March 6, 2025, NVNO TTM free cash flow is -$16.88 million, with the most recent change of -$132.00 thousand (-0.79%) on December 31, 2024.
- Over the past year, NVNO TTM FCF has dropped by -$132.00 thousand (-0.79%).
- NVNO TTM FCF is now -2668.21% below its all-time high of -$609.60 thousand, reached on March 31, 2017.
Performance
NVNO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NVNO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.7% | -19.2% | -0.8% |
| 3 y3 years | -38.1% | -19.2% | -0.8% |
| 5 y5 years | -169.6% | -19.2% | -0.8% |
NVNO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.1% | +10.7% | -61.3% | +0.1% | -43.7% | +10.7% |
| 5 y | 5-year | -169.6% | +10.7% | -341.4% | +0.1% | -193.1% | +10.7% |
| alltime | all time | -734.5% | +10.7% | -738.1% | +0.1% | -2668.2% | +10.7% |
EnVVeno Medical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$16.88 M(-10.7%) | -$5.11 M(+19.2%) | -$16.88 M(+0.8%) |
| Sep 2024 | - | -$4.29 M(+9.3%) | -$16.74 M(+0.4%) |
| Jun 2024 | - | -$3.92 M(+10.2%) | -$16.67 M(-3.8%) |
| Mar 2024 | - | -$3.56 M(-28.5%) | -$17.34 M(-8.2%) |
| Dec 2023 | -$18.89 M(+20.1%) | -$4.98 M(+18.1%) | -$18.89 M(+6.3%) |
| Sep 2023 | - | -$4.22 M(-8.0%) | -$17.78 M(-1.6%) |
| Jun 2023 | - | -$4.58 M(-10.4%) | -$18.06 M(+3.4%) |
| Mar 2023 | - | -$5.11 M(+32.3%) | -$17.46 M(+11.0%) |
| Dec 2022 | -$15.73 M(+28.8%) | -$3.87 M(-14.1%) | -$15.73 M(+4.6%) |
| Sep 2022 | - | -$4.50 M(+12.9%) | -$15.04 M(+16.3%) |
| Jun 2022 | - | -$3.98 M(+17.5%) | -$12.92 M(+10.1%) |
| Mar 2022 | - | -$3.39 M(+7.0%) | -$11.74 M(-3.9%) |
| Dec 2021 | -$12.22 M(+55.5%) | -$3.17 M(+32.8%) | -$12.22 M(+4.5%) |
| Sep 2021 | - | -$2.38 M(-14.8%) | -$11.69 M(-1.9%) |
| Jun 2021 | - | -$2.80 M(-27.6%) | -$11.92 M(+12.8%) |
| Mar 2021 | - | -$3.87 M(+46.4%) | -$10.57 M(+34.5%) |
| Dec 2020 | -$7.86 M | -$2.64 M(+0.9%) | -$7.86 M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$2.62 M(+81.4%) | -$6.85 M(+19.0%) |
| Jun 2020 | - | -$1.44 M(+24.6%) | -$5.76 M(-2.8%) |
| Mar 2020 | - | -$1.16 M(-29.3%) | -$5.92 M(-5.4%) |
| Dec 2019 | -$6.26 M(-1.7%) | -$1.64 M(+7.5%) | -$6.26 M(+3.1%) |
| Sep 2019 | - | -$1.52 M(-5.3%) | -$6.07 M(-3.7%) |
| Jun 2019 | - | -$1.61 M(+7.4%) | -$6.30 M(+1.1%) |
| Mar 2019 | - | -$1.50 M(+3.2%) | -$6.24 M(-2.0%) |
| Dec 2018 | -$6.37 M(+51.2%) | -$1.45 M(-17.4%) | -$6.37 M(+2.7%) |
| Sep 2018 | - | -$1.75 M(+13.7%) | -$6.20 M(+9.6%) |
| Jun 2018 | - | -$1.54 M(-5.2%) | -$5.66 M(+8.2%) |
| Mar 2018 | - | -$1.63 M(+27.0%) | -$5.23 M(+24.1%) |
| Dec 2017 | -$4.21 M(+11.1%) | -$1.28 M(+5.8%) | -$4.21 M(+43.6%) |
| Sep 2017 | - | -$1.21 M(+8.5%) | -$2.93 M(+70.1%) |
| Jun 2017 | - | -$1.11 M(+82.8%) | -$1.72 M(+182.8%) |
| Mar 2017 | - | -$609.60 K | -$609.60 K |
| Dec 2016 | -$3.79 M(+87.5%) | - | - |
| Dec 2015 | -$2.02 M | - | - |
FAQ
- What is enVVeno Medical annual free cash flow?
- What is the all time high annual FCF for enVVeno Medical?
- What is enVVeno Medical annual FCF year-on-year change?
- What is enVVeno Medical quarterly free cash flow?
- What is the all time high quarterly FCF for enVVeno Medical?
- What is enVVeno Medical quarterly FCF year-on-year change?
- What is enVVeno Medical TTM free cash flow?
- What is the all time high TTM FCF for enVVeno Medical?
- What is enVVeno Medical TTM FCF year-on-year change?
What is enVVeno Medical annual free cash flow?
The current annual FCF of NVNO is -$16.88 M
What is the all time high annual FCF for enVVeno Medical?
enVVeno Medical all-time high annual free cash flow is -$2.02 M
What is enVVeno Medical annual FCF year-on-year change?
Over the past year, NVNO annual free cash flow has changed by +$2.02 M (+10.67%)
What is enVVeno Medical quarterly free cash flow?
The current quarterly FCF of NVNO is -$5.11 M
What is the all time high quarterly FCF for enVVeno Medical?
enVVeno Medical all-time high quarterly free cash flow is -$609.60 K
What is enVVeno Medical quarterly FCF year-on-year change?
Over the past year, NVNO quarterly free cash flow has changed by -$824.00 K (-19.23%)
What is enVVeno Medical TTM free cash flow?
The current TTM FCF of NVNO is -$16.88 M
What is the all time high TTM FCF for enVVeno Medical?
enVVeno Medical all-time high TTM free cash flow is -$609.60 K
What is enVVeno Medical TTM FCF year-on-year change?
Over the past year, NVNO TTM free cash flow has changed by -$132.00 K (-0.79%)